While more research is needed, evidence suggests this kind of glucose intolerance can impact obesity and several digestive issues like bloating or abdominal cramps (7, 8)
GHK-Cu is a copper-binding peptide compound widely referenced in preclinical and laboratory research for its interaction with cellular signalling and regenerative pathways
Targeting GLP-1 receptors to reduce nicotine use disorder: Preclinical and clinical evidence
[16] [17] Semaglutide (as Wegovy) is further indicated as an adjunct to a reduced-calorie diet and increased physical activity for weight management, including weight loss and weight maintenance, in adults with obesity (initial BMI 30 kg/m 2 ) or who are overweight (initial BMI 27 kg/m 2 ) and have at least one weight-related comorbidity such as dysglycemia (prediabetes or type 2 diabetes), hypertension, dyslipidemia, or cardiovascular disease
The authors suggest that this variability may be secondary to differences in vitamin C dosing, route of administration and duration of supplementation
INTRODUCTION 2